secwatch.observer — SEC 8-K summary
======================================

Issuer:     Horizon Space Acquisition II Corp. (HSPT)
CIK:        0002032950
Form:       8-K
Filed at:   2025-05-12T23:59:59+00:00
Accession:  0001929980-25-000400
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Horizon Space Acquisition II SPAC to merge with SL Bio at $5.568B enterprise value
--------------------------------------------------------------------------------

- SL Bio develops cellular and gene therapies; will become wholly owned sub of PubCo via two-step merger.
- SPAC shareholders to receive one PubCo ordinary share per share; SL Bio holders get shares based on $5.568B / $10.00 ratio.
- Transactions require approvals from both companies' shareholders, Nasdaq listing, and regulatory clearances.
- Sponsor and certain SL Bio shareholders enter lock-up; shares restricted until 150 days post-close or $12.00 trigger.
- Sponsor support agreement ensures voting in favor; shareholder support agreement covers key SL Bio holders.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2032950/000192998025000400/0001929980-25-000400-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2032950/000192998025000400/hspt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001929980-25-000400

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer